NeuroSense Therapeutics News

6-K: Report of foreign private issuer (related to financial reporting)

Aug 17 04:09

6-K: Report of foreign private issuer (related to financial reporting)

Jun 24 21:25

6-K: Report of foreign private issuer (related to financial reporting)

Jun 18 05:26

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 13 04:33

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 5 21:33

NeuroSense Therapeutics | 20-F: FY2023 Annual Report

Apr 5 04:37

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 28, 2023 22:00

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 17, 2023 04:01

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 24, 2023 04:06

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 1, 2023 20:50

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 15, 2023 04:30

NeuroSense Therapeutics | 20-F: FY2022 Annual Report

Mar 22, 2023 21:21

NeuroSense Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

Jan 20, 2023 05:31

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 31, 2022 21:00

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 31, 2022 21:00

NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 15, 2022 05:28

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 1, 2022 05:10